SUSQUEHANNA INTERNATIONAL GROUP, LLP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$19,536,647
+5.4%
719,847
+19.4%
0.00%
+33.3%
Q2 2023$18,534,345
-8.7%
602,939
+7.0%
0.00%
-25.0%
Q1 2023$20,307,805
-10.4%
563,636
-1.7%
0.00%
-33.3%
Q4 2022$22,661,954
-35.6%
573,430
-34.5%
0.01%
-33.3%
Q3 2022$35,197,000
+4.7%
876,000
+9.5%
0.01%
+12.5%
Q2 2022$33,624,000
+141.5%
799,800
+123.8%
0.01%
+300.0%
Q1 2022$13,925,000
-48.2%
357,400
-47.0%
0.00%
+100.0%
Q4 2021$26,868,000
+180.4%
674,192
+154.3%
0.00%
-50.0%
Q3 2021$9,581,000
-44.8%
265,100
-37.4%
0.00%
-33.3%
Q2 2021$17,361,000
-45.2%
423,527
-41.7%
0.00%
-40.0%
Q1 2021$31,665,000
+3.4%
725,920
+18.6%
0.01%
+150.0%
Q4 2020$30,636,000
+165.7%
612,106
+123.3%
0.00%
-33.3%
Q3 2020$11,531,000
+244.1%
274,108
+297.2%
0.00%
Q2 2020$3,351,00069,0130.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders